Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This is a Phase II trial designed to determine the efficacy and safety of perifosine plus imatinib mesylate in patients with advanced GIST who develop progressive disease or recurrence while receiving imatinib mesylate.
Epistemonikos ID: aa9844cd955049188e25a952b84b4ce396aa864c
First added on: May 04, 2024